by Elisa D'Arcangelo | Nov 25, 2021
This year, the Till & McCulloch Meetings (TMM) featured two particularly exciting Plenary Sessions for those of us with a passion for the nitty-gritty of stem cell biology: on November 15, a session entitled “Endogenous stem cells and their niches” featured talks...
by Cal Strode | Nov 24, 2021
In a field as fast-paced as regenerative medicine, it’s vital that policy isn’t always playing catch-up. I caught up with Amy Zarzeczny’s presentation at the 2021 Till & McCulloch Meetings to find out how policy can stay ahead — or at least keep...
by Sara M. Nolte | Nov 18, 2021
While I have attended several Till & McCulloch Meetings in the past as a trainee and presenter, I have now had the privilege of attending as a cancer stem cell enthusiast and blogger – and I’m excited to share my perspective on some of the amazing talks! If you...
by Stacey Johnson | Nov 12, 2021
In 2016 I shared a list of podcasts that I thought Signals’ readers might enjoy. I think it’s definitely time to update that list, and I’m excited to tell you about a new podcast that’s about to launch: Commercializing Living Therapies with CCRM. Commercializing...
by Lyla El-Fayomi | Nov 4, 2021
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. This month, I cover a technologically advanced...
Comments